vs
BLACKLINE, INC.（BL）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
REPLIGEN CORP的季度营收约是BLACKLINE, INC.的1.1倍（$197.9M vs $183.2M），REPLIGEN CORP净利率更高（6.7% vs 2.7%，领先4.0%），REPLIGEN CORP同比增速更快（13.6% vs 8.1%），BLACKLINE, INC.自由现金流更多（$26.1M vs $17.6M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 7.9%）
BlackLine是一家美国企业级软件公司，总部位于洛杉矶，在全球设有17个办事处，专注于开发云服务，可实现财务结账全流程自动化与管理，同时覆盖财务合并、发票到回款流程及公司间会计核算等业务场景。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
BL vs RGEN — 直观对比
营收规模更大
RGEN
是对方的1.1倍
$183.2M
营收增速更快
RGEN
高出5.5%
8.1%
净利率更高
RGEN
高出4.0%
2.7%
自由现金流更多
BL
多$8.5M
$17.6M
两年增速更快
RGEN
近两年复合增速
7.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $183.2M | $197.9M |
| 净利润 | $4.9M | $13.3M |
| 毛利率 | 75.2% | 52.5% |
| 营业利润率 | 3.7% | 9.0% |
| 净利率 | 2.7% | 6.7% |
| 营收同比 | 8.1% | 13.6% |
| 净利润同比 | -91.3% | 143.9% |
| 每股收益（稀释后） | $0.07 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BLRGEN
| Q4 25 | $183.2M | $197.9M | ||
| Q3 25 | $178.3M | $188.8M | ||
| Q2 25 | $172.0M | $182.4M | ||
| Q1 25 | $166.9M | $169.2M | ||
| Q4 24 | $169.5M | $174.1M | ||
| Q3 24 | $165.9M | $154.9M | ||
| Q2 24 | $160.5M | $154.1M | ||
| Q1 24 | $157.5M | $151.3M |
净利润BLRGEN
| Q4 25 | $4.9M | $13.3M | ||
| Q3 25 | $5.3M | $14.9M | ||
| Q2 25 | $8.3M | $14.9M | ||
| Q1 25 | $6.1M | $5.8M | ||
| Q4 24 | $56.4M | $-30.3M | ||
| Q3 24 | $17.2M | $-654.0K | ||
| Q2 24 | $76.7M | $3.3M | ||
| Q1 24 | $10.8M | $2.1M |
毛利率BLRGEN
| Q4 25 | 75.2% | 52.5% | ||
| Q3 25 | 75.1% | 53.2% | ||
| Q2 25 | 75.2% | 50.0% | ||
| Q1 25 | 75.5% | 53.6% | ||
| Q4 24 | 75.6% | 26.1% | ||
| Q3 24 | 75.2% | 50.0% | ||
| Q2 24 | 74.9% | 49.8% | ||
| Q1 24 | 75.2% | 49.5% |
营业利润率BLRGEN
| Q4 25 | 3.7% | 9.0% | ||
| Q3 25 | 4.3% | 8.9% | ||
| Q2 25 | 4.4% | 7.6% | ||
| Q1 25 | 2.1% | 3.9% | ||
| Q4 24 | 3.7% | -17.7% | ||
| Q3 24 | 5.0% | -5.1% | ||
| Q2 24 | 1.4% | 1.0% | ||
| Q1 24 | 1.1% | 1.3% |
净利率BLRGEN
| Q4 25 | 2.7% | 6.7% | ||
| Q3 25 | 3.0% | 7.9% | ||
| Q2 25 | 4.8% | 8.2% | ||
| Q1 25 | 3.6% | 3.4% | ||
| Q4 24 | 33.3% | -17.4% | ||
| Q3 24 | 10.4% | -0.4% | ||
| Q2 24 | 47.8% | 2.2% | ||
| Q1 24 | 6.9% | 1.4% |
每股收益（稀释后）BLRGEN
| Q4 25 | $0.07 | $0.24 | ||
| Q3 25 | $0.09 | $0.26 | ||
| Q2 25 | $0.13 | $0.26 | ||
| Q1 25 | $0.10 | $0.10 | ||
| Q4 24 | $0.79 | $-0.55 | ||
| Q3 24 | $0.27 | $-0.01 | ||
| Q2 24 | $0.22 | $0.06 | ||
| Q1 24 | $0.17 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $390.0M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $332.3M | $2.1B |
| 总资产 | $1.8B | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资BLRGEN
| Q4 25 | $390.0M | $767.6M | ||
| Q3 25 | $419.9M | $748.7M | ||
| Q2 25 | $459.1M | $708.9M | ||
| Q1 25 | $479.5M | $697.2M | ||
| Q4 24 | $885.9M | $757.4M | ||
| Q3 24 | $725.3M | $784.0M | ||
| Q2 24 | $616.6M | $809.1M | ||
| Q1 24 | $331.4M | $780.6M |
总债务BLRGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益BLRGEN
| Q4 25 | $332.3M | $2.1B | ||
| Q3 25 | $328.3M | $2.1B | ||
| Q2 25 | $414.0M | $2.1B | ||
| Q1 25 | $417.9M | $2.0B | ||
| Q4 24 | $446.7M | $2.0B | ||
| Q3 24 | $367.9M | $2.0B | ||
| Q2 24 | $325.8M | $2.0B | ||
| Q1 24 | $279.8M | $2.0B |
总资产BLRGEN
| Q4 25 | $1.8B | $2.9B | ||
| Q3 25 | $1.7B | $2.9B | ||
| Q2 25 | $1.8B | $2.9B | ||
| Q1 25 | $1.8B | $2.9B | ||
| Q4 24 | $1.8B | $2.8B | ||
| Q3 24 | $1.7B | $2.8B | ||
| Q2 24 | $1.9B | $2.9B | ||
| Q1 24 | $2.1B | $2.8B |
负债/权益比BLRGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $26.7M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $26.1M | $17.6M |
| 自由现金流率自由现金流/营收 | 14.2% | 8.9% |
| 资本支出强度资本支出/营收 | 0.3% | 4.1% |
| 现金转化率经营现金流/净利润 | 5.46× | 1.93× |
| 过去12个月自由现金流最近4个季度 | $161.5M | $93.9M |
8季度趋势，按日历期对齐
经营现金流BLRGEN
| Q4 25 | $26.7M | $25.7M | ||
| Q3 25 | $63.8M | $48.1M | ||
| Q2 25 | $32.3M | $28.6M | ||
| Q1 25 | $46.7M | $15.0M | ||
| Q4 24 | $43.8M | $39.2M | ||
| Q3 24 | $55.9M | $49.3M | ||
| Q2 24 | $40.7M | $42.2M | ||
| Q1 24 | $50.4M | $44.7M |
自由现金流BLRGEN
| Q4 25 | $26.1M | $17.6M | ||
| Q3 25 | $63.3M | $43.4M | ||
| Q2 25 | $31.4M | $21.5M | ||
| Q1 25 | $40.8M | $11.4M | ||
| Q4 24 | $43.0M | $33.6M | ||
| Q3 24 | $55.5M | $42.3M | ||
| Q2 24 | $40.0M | $37.4M | ||
| Q1 24 | $50.1M | $36.4M |
自由现金流率BLRGEN
| Q4 25 | 14.2% | 8.9% | ||
| Q3 25 | 35.5% | 23.0% | ||
| Q2 25 | 18.2% | 11.8% | ||
| Q1 25 | 24.4% | 6.8% | ||
| Q4 24 | 25.4% | 19.3% | ||
| Q3 24 | 33.5% | 27.3% | ||
| Q2 24 | 24.9% | 24.3% | ||
| Q1 24 | 31.8% | 24.0% |
资本支出强度BLRGEN
| Q4 25 | 0.3% | 4.1% | ||
| Q3 25 | 0.3% | 2.5% | ||
| Q2 25 | 0.6% | 3.9% | ||
| Q1 25 | 3.6% | 2.1% | ||
| Q4 24 | 0.4% | 3.2% | ||
| Q3 24 | 0.2% | 4.5% | ||
| Q2 24 | 0.4% | 3.1% | ||
| Q1 24 | 0.2% | 5.5% |
现金转化率BLRGEN
| Q4 25 | 5.46× | 1.93× | ||
| Q3 25 | 12.07× | 3.23× | ||
| Q2 25 | 3.90× | 1.92× | ||
| Q1 25 | 7.72× | 2.57× | ||
| Q4 24 | 0.78× | — | ||
| Q3 24 | 3.24× | — | ||
| Q2 24 | 0.53× | 12.70× | ||
| Q1 24 | 4.66× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BL
| Subscription And Circulation | $173.2M | 95% |
| Technology Service | $10.0M | 5% |
RGEN
暂无分部数据
